SAN DIEGO, April 26 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company’s previously announced 1-for-25 reverse stock split is now effective, and the Company’s common stock will begin trading on a split adjusted basis on the NYSE Amex when the market opens today.
